Aurigene Pharmaceutical opens biologics facility in Hyderabad, India [Yahoo! Finance]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
The 70,000ft² facility is equipped to provide process and analytical development, as well as small-scale manufacturing of antibodies and other recombinant proteins for preclinical and early-phase clinical trials. The process and analytical development laboratories at the facility are already operational and the manufacturing capacity is expected to be commissioned later in 2024. The facility features robust equipment and control systems and is supported by a skilled workforce to ensure a smooth transition to large-scale commercial current good manufacturing practice operations. The new facility complements Aurigene's existing discovery capabilities and infrastructure, which focus on a range of recombinant proteins. These proteins include monoclonal antibodies, bi and multi-specifics, immune-fusion molecules, antibody-drug conjugates and other complex proteins. With the opening of the Hyderabad facility, Aurigene is equipped to offer comprehensive end-to-end services, from d
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Active Pharmaceutical Ingredients (APIs) Market Size Expected to Reach USD 344.91 Billion by 2032 [Yahoo! Finance]Yahoo! Finance
- Global Lenalidomide Drug Market Size To Worth USD 21.47 Billion By 2033 | CAGR Of 5.69% [Yahoo! Finance]Yahoo! Finance
- Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 [Yahoo! Finance]Yahoo! Finance
- Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities [Yahoo! Finance]Yahoo! Finance
- Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing CapabilitiesBusiness Wire
RDY
Earnings
- 5/8/24 - Beat
RDY
Sec Filings
- 6/24/24 - Form 6-K
- 6/21/24 - Form 6-K
- 6/20/24 - Form 6-K
- RDY's page on the SEC website